Shun Lu

Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial

Yi‐Long Wu, Ying Cheng, Jianying Zhou et al. · The Lancet Respiratory Medicine · 2020 · 258 citations

Medicine, Oncology, Pharmacology +17

Liver Sinusoidal Endothelium: A Microenvironment-Dependent Differentiation Program in Rat Including the Novel Junctional Protein Liver Endothelial Differentiation-Associated Protein-1

Cyrill Géraud, Kai Schledzewski, Alexandra Demory et al. · Hepatology · 2010 · 113 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Endothelial transdifferentiation in hepatocellular carcinoma: loss of Stabilin‐2 expression in peri‐tumourous liver correlates with increased survival

Cyrill Géraud, Carolin Mogler, Anja Runge et al. · Liver International · 2013 · 67 citations · Full text

Medicine, Oncology, Pharmacology +17

A Multicenter, Open-Label, Randomized Phase II Controlled Study of rh-Endostatin (Endostar) in Combination with Chemotherapy in Previously Untreated Extensive-Stage Small-Cell Lung Cancer

Shun Lu, Li Lü, Yi Luo et al. · Journal of Thoracic Oncology · 2015 · 44 citations · Full text

Medicine, Oncology, Pharmacology +8

Savolitinib in patients in China with locally advanced or metastatic treatment-naive non-small-cell lung cancer harbouring MET exon 14 skipping mutations: results from a single-arm, multicohort, multicentre, open-label, phase 3b confirmatory study

Yongfeng Yu, Qisen Guo, Yongchang Zhang et al. · The Lancet Respiratory Medicine · 2024 · 21 citations

Medicine, Oncology, Pharmacology +12